Results 151 to 160 of about 416,720 (250)

The accuracy of the Stroke Risk Analysis (SRA) system for predicting atrial fibrillation in patients in the postoperative period of myocardial revascularization. [PDF]

PLoS One, 2023
Serafim KR, Moreira DAR, da Costa PA, Habib RG, Reyes CAS, Fragata CDS.   +5 more
europepmc   +1 more source

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment

European Journal of Haematology, Volume 117, Issue 4, Page 787-798, October 2026.
ABSTRACT Acute Myeloid Leukemia predominantly affects older adults, who often present with comorbidities, functional impairment, and frailty, limiting eligibility for intensive chemotherapy or allogeneic transplantation. Historically, treatment options were restricted to hypomethylating agents, low‐dose cytarabine, hydroxyurea, or supportive care, with
Antonella Bruzzese, Enrica Antonia Martino, Santino Caserta, Maria Eugenia Alvaro, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Ernesto Vigna, Massimo Gentile   +11 more
wiley   +1 more source

Modern Era in Personalized Medicine of Dual Antiplatelet Therapy After Myocardial Revascularization. [PDF]

J Clin Med
Dehghan A, Javadi N, Allaqaband SQ, Jan MF.   +3 more
europepmc   +1 more source

Myocardial Work Evaluation-A Useful Non-Invasive Method to Predict Coronary Artery Sub-Occlusion in a Patient with Unstable Angina and Multiple Myocardial Revascularization Interventions. [PDF]

Diagnostics (Basel), 2023
Gheorghiu A, Arnautu SF, Slovenski M, Malița CD, Tomescu MC, Arnautu DA.   +5 more
europepmc   +1 more source

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009–2019: A Real‐World Study From the UK's Haematological Malignancy Research Network

International Journal of Cancer, Volume 159, Issue 6, Page 1411-1419, 15 September 2026.
Although tyrosine kinase inhibitors (TKIs) improve chronic myeloid leukemia (CML) outcome, long‐term effects remain unclear, particularly in real‐world settings. Here, the authors examined morbidity and mortality in CML patients treated with TKIs between 2009 and 2019 in the United Kingdom.
Eleanor Kane, Alexandra Smith, Debra Howell, Catherine Cargo, Kate Rothwell, Simone Green, Russell Patmore, Eve Roman   +7 more
wiley   +1 more source

Neurological injury in patients with acute myocardial infarction undergoing operative myocardial revascularization within 48 h. [PDF]

J Cardiothorac Surg
Heumüller F, Huenges K, Trigui N, Tulun A, Markscheffel B, Panholzer B, Attmann T, Thiem A, Gravert H, Langguth P, Sommer W, Warnecke G, Grothusen C.   +12 more
europepmc   +1 more source

An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease-State of Art. [PDF]

J Pers Med, 2022
Jonik S, Marchel M, Huczek Z, Kochman J, Wilimski R, Kuśmierczyk M, Grabowski M, Opolski G, Mazurek T.   +8 more
europepmc   +1 more source

Enhancing Blood Circulation With Epsilon‐Near‐Zero (ENZ) Materials via the Far‐Infrared Window of Human Skin

Advanced Science, Volume 13, Issue 49, 3 September 2026.
Epsilon‐near‐zero (ENZ) silicon carbide enables a selective far‐infrared emitter spectrally aligned with the human skin window around 10 µm for wavelength‐matched thermal therapy. In 25 within‐subject trials (50 hands) monitored by laser speckle contrast imaging, SiC increases blood perfusion by 30.2% versus a broadband graphite emitter while ...
Wen‐Teng Yao, Shan‐Chiao Yang, Ming‐Feng Tsai, Hsuen‐Li Chen   +3 more
wiley   +1 more source

Molecular and Cellular Mechanisms of Cardioplegic Protection in Surgical Myocardial Revascularization. [PDF]

Cells
Lazović DM, Karadžić Kočica M, Ivanišević D, Aleksić V, Kočica MJ, Grujić D, Mihajlović JM, Cvetković D, Juričić SA.   +8 more
europepmc   +1 more source

Effectiveness of home-rehabilitation in patients after an acute coronary syndrome and myocardial revascularization. [PDF]

Int J Cardiol Cardiovasc Risk Prev, 2022
Werren M, Valent F, Di Chiara A.
europepmc   +1 more source